Article
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.
JAMA network open - 3 Sept 2024
Kaphingst Kimberly A, Kohlmann Wendy K, Lorenz Chambers Rachelle, Bather Jemar R, Goodman Melody S, Bradshaw Richard L, Chavez-Yenter Daniel, Colonna Sarah V, Espinel Whitney F, Everett Jessica N, Flynn Michael, Gammon Amanda, Harris Adrian, Hess Rachel, Kaiser-Jackson Lauren, Lee Sang, Monahan Rachel, Schiffman Joshua D, Volkmar Molly, Wetter David W, Zhong Lingzi, Mann Devin M, Ginsburg Ophira, Sigireddi Meenakshi, Kawamoto Kensaku, Del Fiol Guilherme, Buys Saundra S
Abstract excerpt
Importance: Increasing numbers of unaffected individuals could benefit from genetic evaluation for inherited cancer susceptibility. Automated conversational agents (ie, chatbots) are being developed for cancer genetics contexts; however, randomized comparisons with standard of care (SOC) are needed. Objective: To examine whether chatbot and SOC approaches are equivalent in completion of pretest cancer genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.